Images
La Vanguardia, Europa Press, Diario Médico, ETHealthworld, among other national and international media, have published an article about the research of the Genomic Instability and Cancer Laboratory at IRB Barcelona. Scientists from this lab have identified the protein EXD2 as a key component for protein sybthesis in mitochondria, the cellular organelles responsible for the production of most energy.
Link to La Vanguardia
Link to Europa Press
Link to Diario Médico
Link to ETHealthworld
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
